Sirona Biochem (TSE:SBM) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Sirona Biochem Corp. partners with Stonegate Healthcare Partners to boost business development and investor relations, focusing on their innovative anti-aging ingredient, GlycoProteMim. The collaboration aims to tap into Stonegate’s vast network and expertise to enhance GlycoProteMim’s market presence in the skincare industry. This strategic partnership is expected to elevate Sirona’s global reach and accelerate the commercialization of their proprietary anti-aging solutions.
For further insights into TSE:SBM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue